PINK
SSMXY

Sysmex Corp

Medical Instruments & Supplies
Healthcare

Prices are adjusted according to historical splits.

Sysmex Corp Stock Price

Vitals

Today's Low:
$25.88
Today's High:
$25.975
Open Price:
$25.92
52W Low:
$24.75
52W High:
$36.57
Prev. Close:
$26.05
Volume:
67212

Company Statistics

Market Cap.:
$10.90 billion
Book Value:
960.5535
Revenue TTM:
$419.82 billion
Operating Margin TTM:
18.49%
Gross Profit TTM:
$190.59 billion
Profit Margin:
11.05%
Return on Assets TTM:
9.48%
Return on Equity TTM:
12.1%

Company Profile

Sysmex Corp had its IPO on under the ticker symbol SSMXY.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Sysmex Corp has a staff strength of 9,500 employees.

Stock update

Shares of Sysmex Corp opened at $25.92 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $25.88 - $25.98, and closed at $25.89.

This is a -0.61% slip from the previous day's closing price.

A total volume of 67,212 shares were traded at the close of the day’s session.

In the last one week, shares of Sysmex Corp have slipped by -3.75%.

Sysmex Corp's Key Ratios

Sysmex Corp has a market cap of $10.90 billion, indicating a price to book ratio of 4.9358 and a price to sales ratio of 0.0344.

In the last 12-months Sysmex Corp’s revenue was $419.82 billion with a gross profit of $190.59 billion and an EBITDA of $110.36 billion. The EBITDA ratio measures Sysmex Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sysmex Corp’s operating margin was 18.49% while its return on assets stood at 9.48% with a return of equity of 12.1%.

In Q2, Sysmex Corp’s quarterly earnings growth was a positive 7.3% while revenue growth was a positive 10.8%.

Sysmex Corp’s PE and PEG Ratio

Forward PE
30.3951
Trailing PE
34.7333
PEG
0

Its diluted EPS in the last 12-months stands at $0.75 per share while it has a forward price to earnings multiple of 30.3951 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sysmex Corp’s profitability.

Sysmex Corp stock is trading at a EV to sales ratio of 0.0339 and a EV to EBITDA ratio of 0.1347. Its price to sales ratio in the trailing 12-months stood at 0.0344.

Sysmex Corp stock pays annual dividends of $80 per share, indicating a yield of 1.13% and a payout ratio of 36.8%.

Balance sheet and cash flow metrics

Total Assets
$535.50 billion
Total Liabilities
$96.95 billion
Operating Cash Flow
$0
Capital Expenditure
$10.07 billion
Dividend Payout Ratio
36.8%

Sysmex Corp ended 2024 with $535.50 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $535.50 billion while shareholder equity stood at $402.08 billion.

Sysmex Corp ended 2024 with $0 in deferred long-term liabilities, $96.95 billion in other current liabilities, 14504000000.00 in common stock, $334.03 billion in retained earnings and $17.87 billion in goodwill. Its cash balance stood at $62.91 billion and cash and short-term investments were $63.89 billion. The company’s total short-term debt was $8,269,000,000 while long-term debt stood at $0.

Sysmex Corp’s total current assets stands at $288.65 billion while long-term investments were $0 and short-term investments were $982.00 million. Its net receivables were $119.41 billion compared to accounts payable of $26.81 billion and inventory worth $81.76 billion.

In 2024, Sysmex Corp's operating cash flow was $0 while its capital expenditure stood at $10.07 billion.

Comparatively, Sysmex Corp paid $0.37 in dividends in 2024.

Other key metrics

Current Trading Price
$25.89
52-Week High
$36.57
52-Week Low
$24.75
Analyst Target Price
$

Sysmex Corp stock is currently trading at $25.89 per share. It touched a 52-week high of $36.57 and a 52-week low of $36.57. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $29.98 and 200-day moving average was $31.86 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 1.3% are held by institutions.

Frequently Asked Questions About Sysmex Corp

The stock symbol (also called stock or share ticker) of Sysmex Corp is SSMXY

The IPO of Sysmex Corp took place on

Similar Industry Stocks (Medical Instruments & Supplies)

Last Price
Chg
Chg%
$79.65
-2.5
-3.04%
Bajaj Auto Ltd (532977)
$4819.35
14.55
+0.3%
HUBTOWN LTD. (HUBTOWN)
$52.04
-0.32
-0.61%
$0.14
0
+0.28%
$375.35
-11.65
-3.01%
$12.49
0.59
+4.96%
NLC India Ltd (NLCINDIA)
$127.7
-13.65
-9.66%
$9.96
0.1
+1.01%
$0
0
+20%
$1.33
0.34
+34.34%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Address

1-5-1 Wakinohama-kaigandori, Kobe, Japan, 651-0073